Calgaroto Nicéia Spanholi, Thomé Gustavo Roberto, da Costa Pauline, Baldissareli Jucimara, Hussein Fátima Abdala, Schmatz Roberta, Rubin Maribel A, Signor Cristiane, Ribeiro Daniela Aymone, Carvalho Fabiano Barbosa, de Oliveira Lizielle Souza, Pereira Luciane Belmonte, Morsch Vera Maria, Schetinger Maria Rosa Chitolina
Programa de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica, Centro de Ciências Naturais e Exatas, Departamento de Química, Universidade Federal de Santa Maria, Campus Universitário, Santa Maria, Rio Grande do Sul, Brazil.
Cell Biochem Funct. 2014 Aug;32(6):502-10. doi: 10.1002/cbf.3044. Epub 2014 Jun 19.
Diabetes is associated with long-term complications in the brain and reduced cognitive ability. Vitamin D3 (VD3 ) appears to be involved in the amelioration of hyperglycaemia in streptozotocin (STZ)-induced diabetic rats. Our aim was to analyse the potential of VD3 in avoiding brain damage through evaluation of acetylcholinesterase (AChE), Na(+) K(+) -adenosine triphosphatase (ATPase) and delta aminolevulinate dehydratase (δ-ALA-D) activities and thiobarbituric acid reactive substance (TBARS) levels from cerebral cortex, as well as memory in STZ-induced diabetic rats. Animals were divided into eight groups (n = 5): control/saline, control/metformin (Metf), control/VD3 , control/Metf + VD3 , diabetic/saline, diabetic/Metf, diabetic/VD3 and diabetic/Metf + VD3 . Thirty days after treatment, animals were submitted to contextual fear-conditioning and open-field behavioural tests, after which they were sacrificed and the cerebral cortex was dissected. Our results demonstrate a significant memory deficit, an increase in AChE activity and TBARS levels and a decrease in δ-ALA-D and Na(+) K(+) -ATPase activities in diabetic rats when compared with the controls. Treatment of diabetic rats with Metf and VD3 prevented the increase in AChE activity when compared with the diabetic/saline group. In treated diabetic rats, the decrease in Na(+) K(+) -ATPase was reverted when compared with non-treated rats, but the increase in δ-ALA-D activity was not. VD3 prevented diabetes-induced TBARS level and improved memory. Our results show that VD3 can avoid cognitive deficit through prevention of changes in important enzymes such as Na(+) K(+) -ATPase and AChE in cerebral cortex in type 1 diabetic rats.
糖尿病与大脑的长期并发症以及认知能力下降有关。维生素D3(VD3)似乎参与改善链脲佐菌素(STZ)诱导的糖尿病大鼠的高血糖症。我们的目的是通过评估大脑皮层中乙酰胆碱酯酶(AChE)、钠钾腺苷三磷酸酶(Na(+)K(+) -ATPase)和δ-氨基乙酰丙酸脱水酶(δ-ALA-D)的活性以及硫代巴比妥酸反应性物质(TBARS)水平,以及STZ诱导的糖尿病大鼠的记忆力,来分析VD3在避免脑损伤方面的潜力。将动物分为八组(n = 5):对照组/生理盐水、对照组/二甲双胍(Metf)、对照组/VD3、对照组/Metf + VD3、糖尿病组/生理盐水、糖尿病组/Metf、糖尿病组/VD3和糖尿病组/Metf + VD3。治疗30天后,对动物进行情境恐惧条件反射和旷场行为测试,之后将它们处死并解剖大脑皮层。我们的结果表明,与对照组相比,糖尿病大鼠存在明显的记忆缺陷、AChE活性和TBARS水平升高以及δ-ALA-D和Na(+)K(+) -ATPase活性降低。与糖尿病/生理盐水组相比,用Metf和VD3治疗糖尿病大鼠可防止AChE活性升高。在治疗的糖尿病大鼠中,与未治疗的大鼠相比,Na(+)K(+) -ATPase的降低得到了逆转,但δ-ALA-D活性的升高没有得到逆转。VD3可预防糖尿病诱导的TBARS水平升高并改善记忆力。我们的结果表明,VD3可以通过预防1型糖尿病大鼠大脑皮层中重要酶如Na(+)K(+) -ATPase和AChE的变化来避免认知缺陷。